Tilray Brands (NASDAQ:TLRY) Stock Price Down 2.7% – What’s Next?

Shares of Tilray Brands, Inc. (NASDAQ:TLRYGet Free Report) traded down 2.7% during mid-day trading on Wednesday . The company traded as low as $4.71 and last traded at $4.75. 3,387,659 shares traded hands during trading, a decline of 22% from the average session volume of 4,329,433 shares. The stock had previously closed at $4.88.

Key Headlines Impacting Tilray Brands

Here are the key news stories impacting Tilray Brands this week:

  • Neutral Sentiment: Tilray’s craft beer and spirits brands are rolling out a series of promotional campaigns, including BrewDog Father’s Day marketing in the U.K., U.S. summer soccer watch parties, and Breckenridge Brewery fan activations, which may help support brand visibility and seasonal traffic. Article Title
  • Neutral Sentiment: Breckenridge Distillery launched a limited-release Patriotic Reserve Bourbon ahead of Independence Day and America’s 250th anniversary, adding another consumer-brand catalyst for Tilray’s beverage portfolio. Article Title
  • Neutral Sentiment: Broader cannabis-sector optimism around potential U.S. rescheduling is keeping Tilray on investor watchlists, but the news is more of an industry theme than a direct near-term financial catalyst. Article Title
  • Negative Sentiment: Recent market commentary focused on Tilray’s weak share performance and suggested the stock could fall further, reinforcing negative sentiment among traders. Article Title
  • Negative Sentiment: Technical and fundamental pressure remains a concern, with the stock well below key moving averages and prior earnings having missed profit expectations, which can weigh on investor confidence. Article Title

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Roth Mkm raised shares of Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a report on Thursday, April 2nd. ATB Cormark Capital Markets lowered their target price on shares of Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating on the stock in a report on Thursday, April 2nd. TD Cowen lowered their target price on shares of Tilray Brands from $10.00 to $7.00 and set a “buy” rating on the stock in a report on Monday, March 30th. Weiss Ratings cut shares of Tilray Brands from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 13th. Finally, Wall Street Zen raised shares of Tilray Brands from a “sell” rating to a “hold” rating in a report on Saturday, March 21st. Three equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Tilray Brands currently has an average rating of “Hold” and a consensus target price of $11.50.

Get Our Latest Stock Analysis on TLRY

Tilray Brands Price Performance

The business’s 50-day moving average price is $5.88 and its 200 day moving average price is $7.42. The stock has a market capitalization of $553.61 million, a PE ratio of -0.35 and a beta of 1.88. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.66 and a current ratio of 2.79.

Tilray Brands (NASDAQ:TLRYGet Free Report) last released its quarterly earnings results on Wednesday, April 1st. The company reported ($0.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.10). The firm had revenue of $206.73 million for the quarter, compared to analysts’ expectations of $201.35 million. Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. During the same quarter last year, the firm earned ($0.87) earnings per share. Research analysts forecast that Tilray Brands, Inc. will post -0.58 earnings per share for the current year.

Insider Activity at Tilray Brands

In other news, Director David G. Hopkinson sold 33,556 shares of the business’s stock in a transaction on Tuesday, April 21st. The shares were sold at an average price of $6.94, for a total transaction of $232,878.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.84% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in TLRY. AQR Capital Management LLC grew its position in Tilray Brands by 1,839.7% in the first quarter. AQR Capital Management LLC now owns 607,054 shares of the company’s stock worth $399,000 after acquiring an additional 575,757 shares in the last quarter. XTX Topco Ltd purchased a new position in Tilray Brands in the second quarter worth $112,000. Cerity Partners LLC grew its position in Tilray Brands by 98.5% in the second quarter. Cerity Partners LLC now owns 92,560 shares of the company’s stock worth $38,000 after acquiring an additional 45,929 shares in the last quarter. Ausdal Financial Partners Inc. purchased a new position in Tilray Brands in the second quarter worth $939,000. Finally, Bank of America Corp DE grew its position in Tilray Brands by 26.5% in the second quarter. Bank of America Corp DE now owns 311,810 shares of the company’s stock worth $129,000 after acquiring an additional 65,379 shares in the last quarter. 9.35% of the stock is currently owned by hedge funds and other institutional investors.

About Tilray Brands

(Get Free Report)

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.

Featured Stories

Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.